Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
19 April 2024
Innovative Technology Insights
AI 2030 Show With Nikhil Pradhan
Nikhil Pradhan joins FinTech4Good’s AI 2030 show to explore the legal risks and rewards of generative AI as it becomes more integrated into the business environment.
18 April 2024
Events
IP Strategy Workshop: Using Your IP to Achieve Business Objectives | Dynamo Energy Hub April Founders Forum
Foley Partner James De Vellis presented at the April Founders Forum meeting for Dynamo Energy Hub, a global network of clean energy thought leaders, on tools cleantech companies need to identify to execute a focused intellectual property strategy.
18 April 2024
Events
2024 Global Cyber Security Initiative (GCSI 2024) 5th Annual Conference
Foley partner Aaron Tantleff, a member of the firm’s Technology Transactions, Cybersecurity, and Privacy Practice, is participating as one of two distinguished keynote speakers at the GCSI 5th Annual Conference in Chicago on April 18.